A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies

Prajwal C. Boddu, Jayastu Senapati, Farhad Ravandi-Kashani, Elias J. Jabbour, Nitin Jain, Mary Ayres, Yuling Chen, Michael J. Keating, Hagop M. Kantarjian, Varsha Gandhi, Tapan M. Kadia

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences